Aim of the study~To assess the difference in patients' clinical status improvement between patients.~To detect time to improvement in oxygenation among both groups.~To detect duration of hospitalization and mortality rate in both groups.~To detect incidence and duration of mechanical ventilation in both treatment arms.~To monitor of adverse events of both drugs
Comparison outcomes of a large cohort of moderate and severe COVID-19 patients received different Antiviral and Anti Inflammatory Drugs.